Stock Events

Stock Events

Instil Bio 

€6.00
19
+€0.15+2.56% 19:29 Today

Statistics

Day High
6
Day Low
5.75
52W High
6.85
52W Low
4.78
Volume
-
Avg. Volume
-
Mkt Cap
40.69M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 16Expected
Q3 2025
Q1 2026
Q2 2026
Next
-2.03
-1.4
-0.78
-0.15
Expected EPS
-0.1523795
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-62.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5GT0.F. It's not an investment recommendation.
Coca-Cola
6
KO
Apple
5
AAPL
Microsoft
5
MSFT
Tesla
5
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Allogene Therapeutics
ALLO
Mkt Cap407.68M
Allogene Therapeutics, Inc. is involved in the development of allogeneic CAR T therapies for cancer, similar to Instil Bio's focus on T-cell therapies.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc., through its acquisition of Kite Pharma, competes in the development of CAR T-cell therapies, a direct competitor to Instil Bio's TIL therapies.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics AG is engaged in the development of gene-based therapies, including CAR T-cell therapies, competing in the gene and cell therapy space with Instil Bio.
Novartis
NVS
Mkt Cap303.67B
Novartis AG, with its approved CAR T-cell therapy Kymriah, competes in the oncology segment, directly challenging Instil Bio's therapeutic approach.
Precigen
PGEN
Mkt Cap2.48B
Precigen, Inc. is a biotechnology company that develops gene and cell therapies, including CAR T-cell therapies, competing in the same space as Instil Bio.
Fate Therapeutics
FATE
Mkt Cap249.23M
Fate Therapeutics, Inc. is developing programmed cellular immunotherapies, including NK and T-cell therapies for cancer, competing in the cell therapy arena with Instil Bio.

About

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Show More
CEO
Bronson Crouch
Employees
17
Country
United States
ISIN
US45783C2008
WKN
000A3E2GE

Listings

XNAS
US
TIL
F
DE
5GT0.F
BOATS
BOATS
TIL.BOATS

0 Comments

Share your thoughts

FAQs

What is Instil Bio stock price today?▼
The current price of 5GT0.F is €6.00 EUR — it has increased by +2.56% in the past 24 hours. Watch Instil Bio stock price performance more closely on the chart.
What is Instil Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Instil Bio stocks are traded under the ticker 5GT0.F.
What is Instil Bio market cap?▼
Today Instil Bio has the market capitalization of 40.69M
When is the next Instil Bio earnings date?▼
Instil Bio is going to release the next earnings report on November 16, 2026.
What were Instil Bio earnings last quarter?▼
5GT0.F earnings for the last quarter are -0.55 EUR per share, whereas the estimation was -0.3 EUR resulting in a -80% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Instil Bio revenue for the last year?▼
Instil Bio revenue for the last year amounts to 0 EUR.
What is Instil Bio net income for the last year?▼
5GT0.F net income for the last year is -62.77M EUR.
How many employees does Instil Bio have?▼
As of November 2, 2026, the company has 17 employees.
In which sector is Instil Bio located?▼
Instil Bio operates in the Health & Wellness sector.
When did Instil Bio complete a stock split?▼
The last stock split for Instil Bio was on December 8, 2023 with a ratio of 1:20.
Where is Instil Bio headquartered?▼
Instil Bio is headquartered in DALLAS, United States.